期刊文献+

时间治疗与常规治疗非小细胞肺癌的比较 被引量:3

下载PDF
导出
摘要 目的 在没有新的治疗方法和药物的条件下 ,提高疗效 ,增加耐受 ,减少毒性已经成为治疗非小细胞肺癌(NSCLC)的关键。本文通过时间治疗和常规治疗的对照 ,观察两种方法治疗NSCLC的疗效和不良反应。方法  5 4例晚期NSCLC初治患者随机分为常规治疗组和时间治疗组两组 ,通过EPI(依托泊苷、顺铂、异环磷酰胺 )治疗 ,常规治疗组在上午 8时开始治疗 ,而时间治疗组在晚上 8时开始治疗。观察治疗效果和不良反应。结果 时间治疗组与常规治疗组比较 ,疗效较好 ,而不良反应较小。结论 时间治疗可望成为一种新的治疗NSCLC的有效方法。
出处 《四川医学》 CAS 2005年第3期288-289,共2页 Sichuan Medical Journal
  • 相关文献

参考文献6

二级参考文献13

  • 1赵庆春.原子吸收分光光度法测定顺铂尿药浓度[J].沈阳部队医,1993,6(5):938-9.
  • 2Hanna NH, Sandier AB, Loehrer PJ Sr, et al. Maintenance daily oral etoposide versus no further therapy following induction chemotherapy with etoposide plus ifosfamide plus cisplatin in extensive small-cell lung cancer. a Hoosier Oncology Group randomized
  • 3Fukuoka M, Furuse K, Saijo N, et al. Randomized trial of cyclophosphamide, doxorubicin, and vincristine versus cisplatin and etoposide versus alternation of these regimens in small-cell lung cancer. J Natl Cancer Inst,1991,83(12): 855-861.
  • 4Roth BJ, Johnson DH, Einhorn LH, et al. Randomized study of cyclophosphamide, doxorubicin, and vincristine versus etoposide and cisplatin versus alternation of these two regimens in extensive small-cell lung cancer: a phase Ⅲ trial of the Southeastern Ca
  • 5Rowland KM Jr, Loprinzi CL, Shaw EG, et al. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer:a North Central Cancer Treatment Group study. J Clin Oncol,199
  • 6Pujol JL, Daures JP, Riviere A, et al. Etoposide plus cisplatin with or without the combination of 4'-epidoxorubiein plus cyclophosphamide in treatment of extensive small-cell lung cancer: a French Federation of Cancer Institutes multicenter phase Ⅲ rand
  • 7Hanna N, Ansari R, Fisher W, et al. Etoposide, ifosfamide and cisplatin (VIP) plus concurrent radiation therapy for previously untreated limited small cell lung cancer (SCLC): a Hoosier Oncol ogy Group (HOG) phase Ⅱ study. Lung Cancer, 2002,35 (3) :293-2
  • 8Mennecier B, Jacoulet P, Dubiez A, et al. Concurrent cisplatin/et oposide chemotherapy plus twice daily thoracic radiotherapy in limited stage small cell lung cancer: a phase Ⅱ study. Lung Cancer,2000,27(3) : 137-143.
  • 9Zochbauer-Muller S, Pirker R, Huber H. Treatment of small cell lung cancer patients. Ann Oncol, 1999,10(Suppl 6): 83-91.
  • 10Loehrer PJ Sr, Ansari R, Gonin R, et al. Cisplatin plus etoposide with and without ifosfamide in extensive small-cell lung cancer: a Hoosier Oncology Group study. J Clin Oncol, 1995,13(10): 25942599.

共引文献15

同被引文献77

引证文献3

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部